The core question about wearable health devices: do they genuinely improve health outcomes, or produce data floods without clinical value? The answer varies substantially by device type and use case.
## Apple Watch and Cardiac Monitoring
**AFib detection**: FDA-cleared in 2018. The Apple Heart Study (400,000 participants, Stanford) demonstrated clinical significance for detecting irregular heart rhythms. AFib — the most common arrhythmia — increases stroke risk fivefold. Early detection has real clinical value.
**ECG**: Apple Watch Series 4+ records single-lead ECGs useful for identifying atrial fibrillation. Single-lead ECG cannot replace 12-lead diagnostic ECG, but serves as a first-line screening tool.
**Irregular Rhythm Notification (IRN)**: passive background monitoring that alerts users to possible irregular heart rhythms — functionally equivalent to 24/7 continuous cardiac monitoring.
## Continuous Glucose Monitors (CGMs): Transformed Diabetes Management
CGMs implant a subcutaneous microsensor that reads interstitial glucose (closely correlated with blood glucose) every 5–15 minutes automatically.
**Leading products**: Dexcom G7, Abbott Freestyle Libre (high China market share), Medtronic Guardian 4.
**Clinical impact**: CGMs significantly improve glycemic control (lower HbA1c) and reduce hypoglycemic events in type 1 diabetes and insulin-dependent type 2 diabetes. Multiple randomized controlled trials confirm these outcomes; CGMs are included in diabetes management guidelines across multiple countries.
**Non-diabetic CGM use**: growing use among healthy populations to understand personal glycemic response patterns lacks strong evidence for meaningful health benefits in this group.
## Next-Generation: Non-Invasive Glucose and Blood Pressure
**Non-invasive glucose**: Apple, Samsung, and others have pursued near-infrared spectroscopy and other non-invasive approaches for years with no mature commercial product achieving clinical accuracy. This remains one of the hardest unsolved challenges in wearable health technology.
**Blood pressure**: Samsung Galaxy Watch PPG-based blood pressure estimation requires regular cuff calibration and has limited accuracy across the full daily range. The FDA-cleared Omron HeartGuide is a wrist-worn oscillometric blood pressure monitor with better accuracy but less convenient wearability.
See [Precision Medicine](https://sunqi.org/precision-medicine-genomics-en/), [AI Medical Diagnosis](https://sunqi.org/ai-medical-diagnosis-tools-en/), and the [Apple Heart Study in NEJM](https://www.nejm.org/doi/full/10.1056/NEJMoa1901183).
